Xconomy

SEPTEMBER 2, 2016

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson.

News 57

News San Diego Journal Technical Review 57

Xconomy

MAY 24, 2018

The research, published in the journal Cell , indicate that several specific strains of bacteria work together in mice to provide neuroprotective effects against epileptic seizures.

Journal 76

Journal UCLA Class Research 76

Xconomy

JUNE 30, 2016

A key scientist involved in integrin research, Harvard University immunologist Tim Springer, is spinning out a biotech startup to develop a new generation of integrin-blocking drugs—pills instead of antibody-based injections—that he says will benefit from “a complete understanding” of these complex molecules.

Startup 40

Startup Invest Journal Research 40

Tech.Co

NOVEMBER 28, 2017

Here at TechCo, we’ve done plenty of lists rounding up the most impressive incubators, accelerators, and coworking spaces in plenty of major cities and across a variety of sectors, from the best healthcare accelerators to a collection of the top women-only coworking spaces. The Land O’Lakes Dairy Accelerator. Brooklyn Foodworks.

Incubator 70

Incubator Santa Clarita Technical Advisors FAQ 70

Xconomy

JUNE 3, 2016

It was fitting this week that, in the lead-up to two of biomedicine’s biggest self-celebrations, we were served ample reminder of the industry’s expensive decisions gone wrong. Thousands of others will head to San Francisco for BIO, which has a distinct international flavor. Teva nabbed deutetrabenazine in its $3.2

San Diego 62

San Diego Patents Acquisition News 62

socalTECH

FEBRUARY 23, 2009

San Diego-based Newsforce (www.newsforce.com) is a startup which is looking to take advantage of the hunger of the newspaper and media business for revenue, and has created a product which takes press releases and commercial content, and inserts them onto news sites in "sponsored content" blocks. Vince Bianco: No.

News 124

News Advertising Press Sites 124

Xconomy

APRIL 15, 2019

Earlier this year, Sarepta bought a startup that spun out of. But it plans to open an 85,000 square-foot gene therapy center with 100 employees in Columbus, tapping into a wide-open pipeline from Nationwide Children’s Hospital. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Capital 111

Capital Startup San Diego Journal 111

Xconomy

JULY 8, 2016

This week started with celebrations of America’s birthday, and it has been dominated—biotech-wise—by America’s government. ” —Biogen (NASDAQ: BIIB ) of Cambridge, MA, received good news in Europe: approval for multiple sclerosis treatment daclizumab (Zinbryta), doubling up its nod from the FDA.

Pricing 52

Pricing News Journal Startup 52

Xconomy

AUGUST 26, 2016

Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes, and—much like when Clinton railed against drug pricing last year—biotech indexes promptly plummeted more than 3 percent. —Pfizer wasn’t done after scooping up Medivation.

Pricing 40

Pricing Thousand Oaks Startup Research 40

Xconomy

AUGUST 16, 2016

A recent Wall Street Journal article that raised the possibility of Biogen as the target of another huge pharma buyout cited the lack of productivity as a major driver of M&A in the pharmaceutical industry. The authors made the point that, given the size of companies today, a single garden-variety blockbuster hardly moves the needle.

Product 40

Product Journal Venture Capital Demand 40

SoCal Delicious

OCTOBER 8, 2012

Professor Journal. Student Journal. Tech entrepreneurs and executives from Silicon Valley are moving south and buying up luxury homes in the Los Angeles area. He uses his former home, a just-under 900-square-foot beach bungalow two blocks away, to house Facebook employees visiting from up north. MarketWatch. MarketWatch.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

Xconomy

AUGUST 19, 2016

Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S.

Technical Review 40

Technical Review Patents .Net Study 40

Xconomy

AUGUST 5, 2016

The Wall Street Journal reported that Cambridge, MA-based Biogen (NASDAQ: BIIB ) has drawn interest from the likes of Merck (NYSE: MRK ) and Allergan (NYSE: AGN ) as a possible takeover target. —Meanwhile, scientists from San Diego-based Synthetic Genomics and the J. Along with Bluebird Bio (NASDAQ: BLUE ) and U.K.

News 40

News Thousand Oaks Pricing Report 40

Xconomy

SEPTEMBER 19, 2016

Charley Grant, writing in The Wall Street Journal , commented that, “Any action to curb price increases on older drugs would hurt manufacturers that rely on them to generate growth.” It has started.”

Pricing 40

Pricing Competition Blogging Journal 40

Xconomy

AUGUST 12, 2016

Koch Institute for Integrative Cancer Research founding director Tyler Jacks has spent decades making important contributions in cancer research, but until forming Cambridge, MA-based Dragonfly Therapeutics, he’d never spun a startup out of his own lab at MIT.

Google 40

Google Technical Review News Research 40

Xconomy

OCTOBER 11, 2016

The European Society for Medical Oncology’s annual conference wraps up in Copenhagen today. The company released detailed data at ESMO and published the results in the New England Journal of Medicine. We’ve seen updates on heavyweight immunotherapy programs, potential options for patients with advanced breast cancer, and more.

News 40

News Study Report Santa Monica 40

Xconomy

JULY 17, 2020

If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16 of the top 25 largest early-stage venture capital deals were investments in life science companies. The figures come from the National Venture Capital Association and financial research firm Pitchbook.

Venture Capital 90

Venture Capital Invest Research Capital 90

Xconomy

NOVEMBER 4, 2016

” One of her most recent projects was a biotech startup in concert with industry veteran Tony Coles (pictured with Lindquist, above). Given the city’s dearth of lab space, however, it’s unclear where those startups will go. They aimed to put yeast experiments at the center of drug discovery for neurological diseases. .

Research 40

Research Report Pricing Journal 40

Xconomy

AUGUST 9, 2016

According to the Wall Street Journal, PFWTMs (“people familiar with the matter”) say the new device will look pretty much the same as the iPhone 6s. The combination opened up so many possibilities that app builders have now spent the better part of a decade exploring them. Apple’s iPhone 7 is due out next month.

Software Review 40

Software Review Screening Design Mobile 40

SoCal Delicious

MAY 6, 2012

Right now they’re setting up 500 free corporations for first time entrepreneurs. Named a Woman Making A Difference by the Los Angeles Business Journal, Lisa Nicole Bell brings more than 10 years of experience to her role as the CEO of Inspired Life Media Group. Thank you @eminutes. . Matthew Clough – Founder of Benson Backpacks.

Los Angeles 78

Los Angeles Entrepreneur Angel Fractional CTO 78

Xconomy

OCTOBER 28, 2016

Two “triple” combination regimens for CF , which are meant to expand the reach of its CF drugs, will begin Phase 2 trials by the end of the year, and two additional new CF drugs will start clinical testing in 2017. The news came with some caveats, however, as TheStreet.com explains here. AND DUCHENNE. AND IN OTHER NEWS….

Pricing 40

Pricing Conference News Study 40

Xconomy

DECEMBER 8, 2017

With 2018 around the corner, this was a week to look ahead. At Xconomy, we zeroed in on several clinical trials that could become major stories in the life sciences. Other healthcare milestones are on the way, too. The FDA will consider for the first time whether a video game should be approved as medicine.

Course 66

Course San Diego Journal Company 66

Xconomy

JULY 20, 2018

Time to curl up in your cubicle, pop open one of these in-depth, entertaining reads, and catch up on some of what you missed during a busy week. You’ve made it to Friday. This week we’re taking a look at all the political stories that are coming out of the tech world.

Entertainment 49

Entertainment Buzzfeed Venture Capital Journal 49

Xconomy

NOVEMBER 3, 2017

The rising death toll from opioids has prompted policymakers to try various ways to take on the problem. President Trump’s opioid commission released its final report this week, calling for expansion of drug courts, better physician training, and penalties for insurers that don’t cover treatment.

News 49

News Training Report San Diego 49

Xconomy

DECEMBER 14, 2016

And to get you started, I have a few shows to suggest. If you’re not much of a podcast listener and you have a sense that you’re missing out on a lot of great content, you’re absolutely right. But now is a good time to fix that, thanks to a new profusion of listening options. Fifty of them, in fact.

Content 40

Content San Diego Journal Google 40